Upon arrival to the ED, temp 98.6, HR 91, BP 84/53, RR 22, and pulse ox 91% on room air.
Her labs were notable for transaminitis, thrombocytopenia with Plt 24.
CTA chest demonstrated no pulmonary embolus and known liver and bony mets.
She was tranferred to the [**Hospital Unit Name 153**] the patient underwent an echocardiogram and CTA of the chest, both of which were unrevealing for significant cause of the patients hypotension and SOB.
Family History: Non-contributory  Physical Exam: VS: T 98.0  HR 91  BP 124/71  RR 20-24 O2 94% on 3L NC GEN: NAD, AOX3 HEENT: MMM OP clear, JVP 8cm CARD: RRR, widely split S2, SEM at the LUSB PULM: CTAB, scoliosis ABD: soft, NT, ND, no masses or organomegaly EXT: WWP, no c/c/e NEURO: AOx3, grossly normal   Pertinent Results: Discharge Labs: [**2180-10-11**] WBC-8.9 RBC-4.01* Hgb-11.4* Hct-32.9* MCV-82 MCH-28.5 MCHC-34.8 RDW-16.8* Plt Ct-20* Fibrino-124* Glucose-76 UreaN-23* Creat-0.9 Na-140 K-4.5 Cl-104 HCO3-26 AnGap-15 ALT-146* AST-219* LD(LDH)-2620* AlkPhos-333* TotBili-1.0 Calcium-10.1 Phos-3.3 Mg-2.0 Hapto-<20* .
Micro: [**2180-10-4**] Blood culture x 2: No growth, final [**2180-10-4**] Urine culture: No growth, final .
Diastolic function could not be assessed.
Compared with the prior study (images reviewed) of [**2180-9-20**], the pulmonary artery systolic pressures can be estimated on the current study (and are moderately elevated).
Recommend follow-up chest CT in 12 months to assess for stability.
# Chronic DIC: The patients platelet count and HCT stabalized during this admission but remained low.
Release 24 hr Sig: One (1) Capsule, Sust.
Release 24 hr Sig: One (1) Capsule, Sust.
Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) Tablet PO DAILY (Daily).
Prednisone 10 mg Tablet Sig: as directed Tablet PO once a day for 38 days: 60mg [**10-12**]- [**10-14**], 50mg [**Date range (1) 90497**], 40mg [**Date range (1) 96745**],  30mg [**Date range (1) 103410**], 20mg [**Date range (1) 41492**], 10mg [**Date range (1) 22749**].
A CT scan was negative for pneumonia, pulmonary embolism, or fluid in your lungs.
You underwent pulmonay function testing (PFTs) which showed restrictive abnormalities of your lungs.
Followup Instructions: You have an appointment with Provider: [**First Name4 (NamePattern1) 2747**] [**Last Name (NamePattern1) 5780**], RN Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2180-10-18**] 10:30  You have an appointment with Provider: [**Name10 (NameIs) 706**] Phone:[**Telephone/Fax (1) 1125**] Date/Time:[**2180-12-20**] 9:30  You have an appointment with Provider: [**Name10 (NameIs) 706**] Phone:[**Telephone/Fax (1) 1125**] Date/Time:[**2180-12-20**] 10:00  You have an appointment with Provider: [**Name10 (NameIs) **], [**Name11 (NameIs) **].
Phone: [**Telephone/Fax (1) 3393**] Date/Time: [**2180-10-18**] 10:30am.
Provider: [**Name10 (NameIs) 1570**],INTERPRET W/LAB NO CHECK-IN [**Name10 (NameIs) 1570**] INTEPRETATION BILLING Date/Time:[**2180-11-1**] 11:30 You will see the pulmonologist after this appointment.
Phone [**Telephone/Fax (1) 13341**] Dr. [**Last Name (STitle) 2036**] will follow your blood work and discuss any further test.
